Ani Pharmaceuticals (ANIP) EBT Margin Growth (1y) (2012 - 2026)
Ani Pharmaceuticals (ANIP) EBT Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 896.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 896.00 |
| Mar 31, 2026 | 680.00 |
| Dec 31, 2025 | 1,996.00 |
| Sep 30, 2025 | 3,607.00 |
| Jun 30, 2025 | 664.00 |
| Mar 31, 2025 | -830.00 |
| Dec 31, 2024 | -794.00 |
| Sep 30, 2024 | -2,997.00 |
| Jun 30, 2024 | -616.00 |
| Mar 31, 2024 | 1,641.00 |
| Dec 31, 2023 | 684.00 |
| Sep 30, 2023 | 2,331.00 |
| Jun 30, 2023 | 2,998.00 |
| Mar 31, 2023 | 4,220.00 |
| Dec 31, 2022 | 4,452.00 |
| Sep 30, 2022 | -94.00 |
| Jun 30, 2022 | 1,195.00 |
| Mar 31, 2022 | -4,085.00 |
| Dec 31, 2021 | -4,648.00 |
| Sep 30, 2021 | -1,376.00 |